• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53沉默和无义突变中的甲基化与重复序列

Methylation and repeats in silent and nonsense mutations of p53.

作者信息

Kouidou Sofia, Malousi Andigoni, Maglaveras Nicos

机构信息

Laboratory of Biological Chemistry, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.

出版信息

Mutat Res. 2006 Jul 25;599(1-2):167-77. doi: 10.1016/j.mrfmmm.2006.03.002. Epub 2006 Apr 19.

DOI:10.1016/j.mrfmmm.2006.03.002
PMID:16620878
Abstract

All exonic CG sequences in p53 are methylated; this epigenetic modification is correlated with frequent G:C-->A:T transitions in p53. Recent reports reveal the presence in p53 of non-CG methylation in CC and CCC sequences, complementary to sites of selective guanosine adduct formation (GG and GGG), and the association of genetic instability with methylation at repetitive sequences. We presently investigated the distribution of methylation sites and repetitive elements in silent and nonsense p53 mutations (2051) among the IARC's TP53 somatic mutation database for exons 5-8. Silent mutations are nonrandom, but mostly involve G:C-->A:T transitions (62%); in particular C-->T mutations (39% of all silent mutations) are mostly correlated with CC and CCC sequences, while G-->A mutations with GG sequences. Sequence analysis of all non-G:C-->A:T silent mutations reveals the frequent formation of new methylation sites (CG), new CCC and GGG sequences in the resulting sequence, refinement of symmetry elements at interrupted microsatellite-like sequences and formation of small repeats (55.3%). The G:C-->A:T silent mutations characterize cancers associated with cigarette smoking (e.g. bladder or lung and bronchus cancer versus colorectal cancer); on the contrary, non-G:C-->A:T silent mutations have similar frequencies in most cancers. Nonsense mutations in exons 5-8, all resulting in mutants lacking amino acids 307-393, which are crucial for p53 activity, were also analyzed. The frequency of nonsense mutations is higher at methylated sites or repeats 1-2 nucleotides removed from methylation sites. Frameshift mutations are also more frequent at repeated sequences. The frequent G:C-->A:T silent mutations could indicate that CC and CCC sequences of exons 5-8 are occasionally targets of non-CpG methylation of cytosine. This process of de novo methylation in the presence of microsatellite-like sequences and small repeats might influence the genetic stability of a variety of genes.

摘要

p53基因所有外显子中的CG序列均发生甲基化;这种表观遗传修饰与p53基因中频繁出现的G:C→A:T转换相关。最近的报告显示,p53基因中存在CC和CCC序列的非CG甲基化,这些序列与选择性鸟嘌呤加合物形成位点(GG和GGG)互补,并且遗传不稳定性与重复序列处的甲基化有关联。我们目前在国际癌症研究机构(IARC)的外显子5 - 8的TP53体细胞突变数据库中,研究了沉默和无义p53突变(2051个)中甲基化位点和重复元件的分布情况。沉默突变并非随机发生,但大多涉及G:C→A:T转换(62%);特别是C→T突变(占所有沉默突变的39%)大多与CC和CCC序列相关,而G→A突变与GG序列相关。对所有非G:C→A:T沉默突变的序列分析显示,在所得序列中频繁形成新的甲基化位点(CG)、新的CCC和GGG序列,中断的微卫星样序列处对称元件的细化以及小重复序列的形成(55.3%)。G:C→A:T沉默突变是与吸烟相关癌症(如膀胱癌或肺癌和支气管癌与结直肠癌相比)的特征;相反,非G:C→A:T沉默突变在大多数癌症中的频率相似。我们还分析了外显子5 - 8中的无义突变,所有这些突变均导致缺乏对p53活性至关重要的氨基酸307 - 393的突变体。无义突变在甲基化位点或距甲基化位点1 - 2个核苷酸的重复序列处频率更高。移码突变在重复序列处也更频繁。频繁出现的G:C→A:T沉默突变可能表明外显子5 - 8的CC和CCC序列偶尔是胞嘧啶非CpG甲基化的靶点。在存在微卫星样序列和小重复序列的情况下这种从头甲基化过程可能会影响多种基因的遗传稳定性。

相似文献

1
Methylation and repeats in silent and nonsense mutations of p53.p53沉默和无义突变中的甲基化与重复序列
Mutat Res. 2006 Jul 25;599(1-2):167-77. doi: 10.1016/j.mrfmmm.2006.03.002. Epub 2006 Apr 19.
2
G:C > A:T mutations and potential epigenetic regulation of p53 in breast cancer.乳腺癌中p53基因的G:C>A:T突变及潜在的表观遗传调控
Breast Cancer Res Treat. 2007 Dec;106(3):351-60. doi: 10.1007/s10549-007-9514-y. Epub 2007 May 16.
3
Non-CpG cytosine methylation of p53 exon 5 in non-small cell lung carcinoma.非小细胞肺癌中p53基因第5外显子的非CpG胞嘧啶甲基化
Lung Cancer. 2005 Dec;50(3):299-307. doi: 10.1016/j.lungcan.2005.06.012. Epub 2005 Aug 25.
4
Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers.甲基化的CpG二核苷酸是苯并[a]芘二醇环氧化物在哺乳动物细胞中诱导的G到T颠换突变的优先靶点:与吸烟相关肺癌中p53突变谱的相似性。
Cancer Res. 2001 Oct 1;61(19):7110-7.
5
Li-Fraumeni and Li-Fraumeni-like syndrome mutations in p53 are associated with exonic methylation and splicing regulatory elements.p53基因中的李-弗劳梅尼综合征及李-弗劳梅尼样综合征突变与外显子甲基化和剪接调控元件相关。
Mol Carcinog. 2009 Oct;48(10):895-902. doi: 10.1002/mc.20537.
6
p53 mutations in lung cancer following radiation therapy for Hodgkin's disease.霍奇金淋巴瘤放疗后肺癌中的p53突变
Cancer Epidemiol Biomarkers Prev. 1996 Feb;5(2):93-8.
7
Hypermethylation of the DNA repair gene MGMT: association with TP53 G:C to A:T transitions in a series of 469 nervous system tumors.DNA修复基因MGMT的高甲基化:与469例神经系统肿瘤系列中TP53基因G:C到A:T的转变相关
Mutat Res. 2004 Oct 4;554(1-2):23-32. doi: 10.1016/j.mrfmmm.2004.02.011.
8
Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers.p53基因中CpG位点的完全甲基化及组织非依赖性甲基化:对人类癌症突变的影响
Oncogene. 1995 Apr 20;10(8):1493-9.
9
Thyroid carcinoma is characterized by genomic instability: evidence from p53 mutations.甲状腺癌以基因组不稳定为特征:来自p53突变的证据。
Mol Genet Metab. 2001 Feb;72(2):155-63. doi: 10.1006/mgme.2000.3114.
10
Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.p53和Ki-ras基因的突变、微卫星不稳定性与结直肠癌的肿瘤起源部位
Oncol Rep. 2005 Sep;14(3):625-31.

引用本文的文献

1
Epigenetic Alterations Upstream and Downstream of p53 Signaling in Colorectal Carcinoma.结直肠癌中p53信号上游和下游的表观遗传改变
Cancers (Basel). 2021 Aug 13;13(16):4072. doi: 10.3390/cancers13164072.
2
In silico structural analysis of sequences containing 5-hydroxymethylcytosine reveals its potential as binding regulator for development, ageing and cancer-related transcription factors.对含有 5-羟甲基胞嘧啶的序列进行计算机结构分析,揭示了其作为与发育、衰老和癌症相关转录因子结合调节剂的潜力。
Epigenetics. 2021 May;16(5):503-518. doi: 10.1080/15592294.2020.1805693. Epub 2020 Sep 2.
3
Karyotype and DNA-Methylation Responses in Myelodysplastic Syndromes following Treatment with Traditional Chinese Formula Containing Arsenic.
砷剂中药治疗骨髓增生异常综合征的核型和 DNA 甲基化反应。
Evid Based Complement Alternat Med. 2012;2012:969476. doi: 10.1155/2012/969476. Epub 2012 Oct 16.
4
Synonymous polymorphisms at splicing regulatory sites are associated with CpGs in neurodegenerative disease-related genes.剪接调控位点的同义多态性与神经退行性疾病相关基因中的 CpG 有关。
Neuromolecular Med. 2010 Sep;12(3):260-9. doi: 10.1007/s12017-009-8111-0. Epub 2010 Jan 14.
5
Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment.p53及p53信号通路中的多态性:在癌症易感性及治疗反应中的作用
J Cell Mol Med. 2009 Mar;13(3):440-53. doi: 10.1111/j.1582-4934.2008.00634.x.
6
Inheritance of an epigenetic mark: the CpG DNA methyltransferase 1 is required for de novo establishment of a complex pattern of non-CpG methylation.表观遗传标记的遗传:从头建立复杂的非CpG甲基化模式需要CpG DNA甲基转移酶1。
PLoS One. 2007 Nov 7;2(11):e1136. doi: 10.1371/journal.pone.0001136.